// App-Quantinova.ai

: CD9 IS AN ADVERSE PROGNOSTIC MARKER AND PROMISING THERAPEUTIC TARGET IN HIGH-RISK PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Chi Zhang

Principal Investigators

  • John Tak Kit Cheung

  • Kathy Yuen Yee Chan

  • Han Wang

  • Toni Ki Fong Man

  • Karen Li

  • Chi Kong Li

  • Kam Tong Leung

Medical Centers

  • Department of Surgery, The Chinese University of Hong Kong, Shatin, Hong Kong

Locations

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Cluster of Differentiation 19

  • Cluster of Differentiation 34

  • Cluster of differentiation 45

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved